Filing metadata

Accession number
0001479290-23-000041
Form type
Form 4
Filer
Revance Therapeutics, Inc.
CIK
CIK 1479290
Filed
Mar 17, 2023
Reporting period
Mar 15, 2023
Description
Insider transaction

Explore SEC Filings Hub